GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MannKind Corp (NAS:MNKD) » Definitions » Cyclically Adjusted PB Ratio

MannKind (MannKind) Cyclically Adjusted PB Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is MannKind Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MannKind Cyclically Adjusted PB Ratio Historical Data

The historical data trend for MannKind's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MannKind Cyclically Adjusted PB Ratio Chart

MannKind Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MannKind Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MannKind's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, MannKind's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MannKind's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MannKind's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where MannKind's Cyclically Adjusted PB Ratio falls into.



MannKind Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

MannKind's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, MannKind's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.912/129.4194*129.4194
=-0.912

Current CPI (Dec. 2023) = 129.4194.

MannKind Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.227 99.695 0.295
201406 -0.588 100.560 -0.757
201409 -0.502 100.428 -0.647
201412 -0.908 99.070 -1.186
201503 -1.186 99.621 -1.541
201506 -1.400 100.684 -1.800
201509 -1.489 100.392 -1.920
201512 -4.086 99.792 -5.299
201603 -4.351 100.470 -5.605
201606 -3.837 101.688 -4.883
201609 -2.495 101.861 -3.170
201612 -1.919 101.863 -2.438
201703 -2.075 102.862 -2.611
201706 -2.115 103.349 -2.649
201709 -2.397 104.136 -2.979
201712 -1.804 104.011 -2.245
201803 -1.771 105.290 -2.177
201806 -1.419 106.317 -1.727
201809 -1.288 106.507 -1.565
201812 -0.936 105.998 -1.143
201903 -1.001 107.251 -1.208
201906 -1.035 108.070 -1.239
201909 -0.895 108.329 -1.069
201912 -0.900 108.420 -1.074
202003 -0.929 108.902 -1.104
202006 -0.785 108.767 -0.934
202009 -0.807 109.815 -0.951
202012 -0.745 109.897 -0.877
202103 -0.697 111.754 -0.807
202106 -0.735 114.631 -0.830
202109 -0.738 115.734 -0.825
202112 -0.832 117.630 -0.915
202203 -0.919 121.301 -0.981
202206 -0.960 125.017 -0.994
202209 -0.903 125.227 -0.933
202212 -0.950 125.222 -0.982
202303 -0.966 127.348 -0.982
202306 -0.971 128.729 -0.976
202309 -0.934 129.860 -0.931
202312 -0.912 129.419 -0.912

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MannKind  (NAS:MNKD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


MannKind Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of MannKind's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


MannKind (MannKind) Business Description

Industry
Traded in Other Exchanges
Address
1 Casper Street, Danbury, CT, USA, 06810
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Executives
Michael Castagna officer: Chief Commercial Officer 25134 RYE CANYON LOOP, SUITE 300, VALENCIA CA 91355
David Thomson officer: VP & Assoc General Counsel 28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Steven B. Binder officer: Chief Financial Officer 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362
Burkhard Blank officer: EVP Chief Medical Officer C/O ACORDA THERAPEUTICS, 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Lauren M Sabella officer: EVP Chief Operating Officer C/O ACORDA THERAPEUTICS, 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
Sanjay R Singh officer: EVP Technical Operations 1 CASPER STREET, DANBURY CT 06810
Alejandro Galindo officer: Chief Commercial Officer 30930 RUSSELL RANCH RD, STE 300, WESTLAKE VILLAGE CA 91362
Stuart A Tross officer: Corp VP, Chief People Officer ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Anthony C Hooper director AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Jennifer Grancio director 30930 RUSSELL RANCH ROAD SUITE 300, WESTLAKE VILLAGE CA 91362
Christine Mundkur director
Sabrina Kay director 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362
David M Kendall officer: Chief Medical Officer 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362
Patrick Mccauley officer: Chief Commercial Officer 30930 RUSSELL RANCH ROAD, SUITE 300, WESTLAKE VILLAGE CA 91362
Barton Courtney officer: Chief Compliance Officer 30930 RUSSELL RANCH ROAD, WESTLAKE VILLAGE CA 91362